Neovasc Revenue and Competitors
Estimated Revenue & Valuation
- Neovasc's estimated annual revenue is currently $8.9M per year.
- Neovasc's estimated revenue per employee is $125,500
- Neovasc's total funding is $385.2M.
Employee Data
- Neovasc has 71 Employees.
- Neovasc grew their employee count by -14% last year.
Neovasc Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $32.4M | 129 | 9% | N/A | N/A |
#2 | $4.3M | 17 | -19% | N/A | N/A |
#3 | $71.5M | 285 | 8% | N/A | N/A |
#4 | $20.3M | 81 | 7% | N/A | N/A |
#5 | $7.8M | 31 | 35% | N/A | N/A |
#6 | $75.3M | 240 | 3% | $53.9M | N/A |
#7 | $267.6M | 1066 | 13% | N/A | N/A |
#8 | $36.6M | 0 | N/A | $1.3B | N/A |
#9 | $38.4M | 153 | 15% | N/A | N/A |
#10 | $10.3M | 41 | 5% | N/A | N/A |
What Is Neovasc?
Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer? for the treatment of refractory angina and the Tiara? technology in development for the transcatheter treatment of mitral valve disease. To receive Neovasc updates via email, please register at: http://www.neovasc.com/register.
keywords:N/A
$385.2M
Total Funding
71
Number of Employees
$8.9M
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neovasc's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Clinical Affairs | |
2 | Sr Clinical Research Associate | |
3 | Quality Engineering Manager | |
4 | Chief Quality Officer | |
5 | VP Human Resources | |
6 | Clinical Study Manager | |
7 | Master Scheduler | |
8 | Principal Clinical Research Associate | |
9 | Senior Engineer | |
10 | Manager, Manufacturing |
Neovasc News
Neovasc is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular...
Neovasc is a specialty medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular...
Healthcare Investment Conference to be held May 2-3, 2022. Fred Colen, Neovasc's Chief Executive Officer, will be presenting at 4:00 pm ET on...
Neovasc Inc. Management's Discussion and Analysis FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 AND 2020 (Expressed in U.S. Dollars) Q3 2021 MANAGEMENT'S DISCUSSION AND ANALYSIS This Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") ...
Neovasc Announces Third Quarter 2021 Financial Results and Provides Corporate Update VANCOUVER and MINNEAPOLIS via NewMediaWire --Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today reported financial results for the third quarter ended September 30, 2021. Third Quarter Highl ...
Other Companies in Richmond Hill
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.6M | 76 | 81% | N/A |
#2 | $25.4M | 78 | 3% | N/A |
#3 | N/A | 80 | 43% | N/A |
#4 | $12M | 80 | 11% | N/A |
#5 | N/A | 83 | 1% | N/A |